ADHD, Moral Panic and the Real Question We Keep Dodging
The ADHD overdiagnosis debate concerns whether rising diagnoses and prescriptions reflect genuine recognition of a disabling condition or a medicalisation of everyday difficulties, and how to balance cautious diagnosis with timely access to treatment so that children and adults are neither stigmatized nor denied help they urgently need.
The headline fight over ADHD is framed as a simple choice: either we are labelling normal childhood as disordered, or we are finally catching up with a neglected condition. Both stories are incomplete. One side points to soaring prescription rates and vague checklists; the other warns that stigma and moral panic stop people from getting care. The real question is not whether ADHD is “real” – clinical evidence says it is – but what price we pay when we either pathologise every fidget or dismiss genuine impairment as bad behaviour. Any honest discussion of the ADHD diagnosis controversy has to hold two truths at once: some people may receive a label they do not need, while many more still go without a diagnosis that could change their lives.
Rising Numbers, Rising Anxiety: Are We Overdiagnosing ADHD?
The sharp rise in ADHD figures makes easy fuel for alarm. An NHS psychiatrist describes how, in their career, ADHD has gone from rare to an estimated 2.5 million people now carrying the diagnosis, with around 270,000 children and young people waiting for an assessment. Prescriptions have been climbing by 18 percent a year since the pandemic. Add in a diagnostic process built on behaviour checklists – often talks excessively, often fidgets, fails to give close attention to detail – and it is no surprise that some clinicians worry the net has become too wide, too subjective.
One documentary, The Great ADHD Myth?, channels this unease, questioning how easily everyday struggles can be reframed as medical illness and how “powerful medicines that can fundamentally change” a child’s personality are being handed out without a fuller public debate. That unease is not illegitimate; it forces us to ask whether we are using diagnosis to fix children or to make them easier to manage in systems that refuse to change.
The Risks We Ignore: Undertreatment, Stigma and Daily Life
While critics of medication dominate headlines, clinicians working in ADHD clinics are alarmed by something else: the human cost of not treating. Two experts point out that underdiagnosis may be a more pressing problem than overdiagnosis, and warn that the moral panic around ADHD means “people don't get treatment” when they need it. One of them spells it out: “No one ever talks about the risks of not getting treatment or delaying treatment. They're huge”.
Those risks are not abstract. For many with pronounced symptoms, daily life feels like “an ongoing war” with their own brain and body, where thoughts race, stimuli overwhelm, and social norms – sitting still in class, staying focused at work, even chatting at a gathering – become exhausting obstacles. When critics frame ADHD treatment risks purely as pharmacological harm, they erase the damage of chronic school failure, lost jobs, accidents, relationship breakdowns and constant shame. The ADHD treatment risks conversation is incomplete unless it includes both medication side effects and the price of letting impairment run unchecked.
Are We Medicating Children or Failing Them? Root Causes and Hard Choices
The ADHD diagnosis controversy is not only about brains; it is about what we demand of children. At the heart of one documentary stands Mason, a 10‑year‑old who has taken lisdexamfetamine for two years and wants to stop. Watching his mother weigh the decision, the psychiatrist behind the film concludes that if a child cannot cope with school unless he takes amphetamines, perhaps the problem lies less in his brain than in what school and society ask of him.
We expect children to sit still for hours in systems built around exam results rather than individual needs, while outside school we hand them phones that fragment attention and push family life to a relentless pace. Yet we locate the fault inside the child’s head. This is the uncomfortable core of the ADHD overdiagnosis debate: where is the line between a disordered brain and a disordered environment? Medication can help a child sit still, but it cannot fix punitive classrooms, crowded curricula or distracted parenting. If we ignore structural causes, we risk using tablets to paper over institutional failures.
A Better Middle Ground: Cautious Diagnosis, Open Doors to Care
Clinical experts argue that the way out of this polarized mess is not to pick a side, but to accept ADHD as a dimensional trait and keep both vigilance and compassion. ADHD exists along a spectrum: some people have mild traits, others are profoundly impaired. Because of this, “a lot is left to the doctor's discretion,” and that makes good assessment practice – gathering history, functional impact, and context – critical. Concerns about misdiagnosis often rest on big epidemiological numbers that simply claim “the rates are too high” without going back to see whether anyone was harmed.
As one expert puts it, “We don't want lots of people being treated with medications who don't need it, but that has to be documented before red flags are flying”. In practical terms, that means improving childhood ADHD assessment while cutting the current backlog of about 270,000 children and young people waiting for evaluation. It means admitting that media narratives and social media misinformation can both inflate self-diagnosis and fuel stigma. And it means judging treatment not by ideology, but by whether it reduces suffering and expands a child’s real options in life.
